Determination of Netrin-1 Levels in Patients that Applied to Emergency Department with Stroke and Its Effects on Survival for 6 Months
American Journal of Internal Medicine
Volume 2, Issue 6, November 2014, Pages: 150-155
Received: Nov. 18, 2014; Accepted: Dec. 19, 2014; Published: Dec. 27, 2014
Views 2445      Downloads 109
Korhan Ivelik, Konya Training and Research Hospital, Emergency Department, Konya, Turkey
Ramazan Koylu, Konya Training and Research Hospital, Emergency Department, Konya, Turkey
Akinci Emine, Konya Training and Research Hospital, Emergency Department, Konya, Turkey
Basar Cander, Konya Training and Research Hospital, Emergency Department, Konya, Turkey
Zerrin Defne Dundar, Konya Training and Research Hospital, Emergency Department, Konya, Turkey
Oznur Koylu, Konya Training and Research Hospital, Biochemistry Department, Konya, Turkey
Haluk Gumus, Konya Training and Research Hospital, Neurology Department, Konya, Turkey
Article Tools
Follow on us
Introduction: We aimed to observe whether there are differences in patients presenting to the emergency department that has stroke, determination of serum levels of netrin-1, and its impact on patient survival and determine the effect on survival and stroke patients according to the type of netrin-1 levels. Methods: The study was held in the Konya Education and Research Hospital, Emergency Department between 1st of August, 2012 and 30th of November, 2012. Patients divided into sub groups after determination of hemorrhagic and ischemic stroke. Control group was created with the patients that did not have stroke. In both groups, Netrin-1 levels were studied. Findings: Totally 131 stroke 51 control patiens were enrolled the study. %13 of the patients were with hemorrhagic where as the other %87 was ischemic stroke. In the stroke group Netrin-1 was lower than the control group (p=0,003 and p<0,001). In order to distinguish between control and case groups, related with Netrin-1 ROC curve was statistically significant 0,739 (%95 Confidence Interval: 0,664-0,814). Best cutoff point for Netrin-1 is determined as 728.4. The sensitivity of Netrin-1 at this point is %71,0; selectivity is %68,6; positive predictive value is %85,3; negative predictive value is %47,9; and finally accuracy rate was found as %70,3. Although in the hemorrhagic stroke Netrin-1 is lower than ischemic stroke, the difference between groups was not statistically significant (p=0,297). There was not statistically significant difference in terms with among the patients the median survival and die patients related with Netrin-1. Discussion: Netrin-1 precursor protein is important for neural and vascular development. Netrin-1 regulates cell migration and axon in the brain in utero. On the other hand, in the SSS damage, injured in sections the migration of adult neural stem cells is located. In determining the prognosis of stroke and mortality in the literature, many markers are used. Result: Our study is the first study on this subject in stroke patients have low levels of netrin-1. According to the type of stroke did not detect a difference in netrin-1 levels. Netrin-1 levels were not associated with mortality.
Stroke, Netrin-1, Survival
To cite this article
Korhan Ivelik, Ramazan Koylu, Akinci Emine, Basar Cander, Zerrin Defne Dundar, Oznur Koylu, Haluk Gumus, Determination of Netrin-1 Levels in Patients that Applied to Emergency Department with Stroke and Its Effects on Survival for 6 Months, American Journal of Internal Medicine. Vol. 2, No. 6, 2014, pp. 150-155. doi: 10.11648/j.ajim.20140206.19
World Health Organisation. Cerebrovascular Disorders (Offset Publications). Geneva: World Health Organization; ISBN 9241700432. OCLC 4757533. 1978.
Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997; 28(2):307-10.
Kothari RU, Brott T, Broderick JP, et al. Emergency physicians. Accuracy in the diagnosis of stroke. Stroke. 1995; 26(12):2238-41.
Shafqat S, Kvedar JC, Guanci MM, et al. Role for telemedicine in acute stroke: feasibility and reliability of remote administration of the NIH Stroke Scale. Stroke. 1999; 30:2141–2145.
Freitas C, Larrivee, B, Eichmann A. Netrins and UNC5 receptors in angiogenesis. Angiogenesis 2008; 11, 23–29.
Basnakian AG. Netrin-1: A potential universal biomarker for acute kidney injury. Article in Press Am J Physiol Renal Physiol. 2008.
Huber AB, Kolodkin AL, Ginty DD, et al. Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. Annu Rev Neurosci 2003, 26:509-563.
Serafini, T., Colamarino, S.A., Leonardo ED, et al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell, 1996; 87, 1001–1014
Wilson BD, Li M, Park KW, et al. Netrins promote developmental and therapeutic angiogenesis. Science, 2006; 313, 640–644.
Ahmed RP, Haider KH, Shujia J, et al.2010. Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway. PLoS One 5, e8576.
Fan, Y., Shen, F., Chen, Y., Hao, Q., Liu, W., Su, H., Young, W.L., Yang, G.Y., 2008. Overexpression of netrin-1 induces neovascularization in the adult mouse brain. J. Cereb. Blood Flow Metab. 28, 1543–1551.
Barbieri A, Giuliani E, Carone C, Pederzoli F, Mascheroni G, Greco G, Stucchi C, Genedani S. Clinical severity of ischemic stroke and neural damage biomarkers In the acute setting: The STROke-MArkers (STROMA) Study. Minerva Anestesiol. 2013 Mar 19.
Abubakar S, Sabir A, Ndakotsu M, Imam M, Tasiu M. Low admission serum albumin as prognostic determinant of 30-day case fatality and adverse functional outcome following acute ischemic stroke. Pan Afr Med J. 2013; 14:53. doi: 10.11604/pamj.2013.14.53.1941. Epub 2013 Feb 7.
Wanby P, Teerlink T, Brudin L , Brattstr¨om L, Nilsson I, Palmqvist P, Carlsson M. (2006). Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosi, 185:271–277.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333: 1581–1587.73) Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 274: 1017–1025
Nakashiba T, Ikeda T, Nishimura S, Tashiro K, Honjo T, Culotti JG, Itohara S: Netrin-G1: a novel glycosyl phosphatidylinositol-linked mammalian netrin that is functionally divergent from classical netrins. J Neurosci 2000, 20:6540-6550.
Serafini T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM, Tessier-Lavigne M: The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 1994, 78:409-424.
Park, K.W., Crouse, D., Lee, M., Karnik, S.K., Sorensen, L.K., Murphy, K.J., Kuo, C.J., Li, D.Y., 2004. The axonal attractant Netrin-1 is an angiogenic factor. Proc. Natl. Acad. Sci. U. S. A. 101, 16210–16215.
Sun H, Le T, Chang TT, Habib A, Wu S, Shen F, Young WL, Su H, Liu J. AAV-mediated netrin-1 overexpression increases peri-infarct blood vessel density and improves motor function recovery after experimental stroke. Neurobiol Dis. 2011 Oct; 44(1):73-83. doi: 10.1016/j.nbd.2011.06.006. Epub 2011 Jun 25.
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase 53 Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999; 282:2019-26.
Huang Y, Jing J, Zhao XQ, Wang CX, Wang YL, Liu GF, Wang CJ, Liu LP, Yang XM, Jiao Y, Jiao Y, Wang LS, Wang YJ, Gu WK. High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese. CNS Neurosci Ther. 2012 Mar; 18(3):261-6.
Hasan N, McColgan P, Bentley P, Edwards RJ, Sharma P. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol. 2012 Aug; 74(2):230-40.
Bielewicz J, Kurzepa J, Czekajska-Chehab E, Stelmasiak Z, Bartosik-Psujek H. Does serum Tau protein predict the outcome of patients with ischemic stroke? J Mol Neurosci. 2011 Mar; 43(3):241-5. doi: 10.1007/s12031-010-9403-4. Epub 2010 Jun 12.
Jensen JK, Ueland T, Atar D, Gullestad L, Mickley H, Aukrust P, Januzzi JL. Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. J Intern Med. 2010 Apr;267(4):410-7. doi: 10.1111/j.1365-2796.2009.02163.x. Epub 2009 Aug 26.
C.R. Canova, C. Courtin, W.H. Reinhart. C-reactive protein (CRP) in cerebrovascular events. Atherosclerosis 1999; 147(1):49–53.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186